Limbal Stem Cells on Bacterial Nanocellulose Carriers for Ocular Surface Regeneration

Small ◽  
2021 ◽  
Vol 17 (10) ◽  
pp. 2003937
Author(s):  
Irene Anton‐Sales ◽  
Laura Koivusalo ◽  
Heli Skottman ◽  
Anna Laromaine ◽  
Anna Roig
Cornea ◽  
2007 ◽  
Vol 26 (4) ◽  
pp. 473-478 ◽  
Author(s):  
Ahmed Galal ◽  
Juan J Perez-Santonja ◽  
Jose Luis Rodriguez-Prats ◽  
Marta Abad ◽  
Jorge Alio

PLoS ONE ◽  
2020 ◽  
Vol 15 (12) ◽  
pp. e0244327
Author(s):  
Antonio J. Villatoro ◽  
Cristina Alcoholado ◽  
María del Carmen Martín-Astorga ◽  
Gustavo Rico ◽  
Viviana Fernández ◽  
...  

Limbal stem cells (LSCs) are a quiescent cell population responsible for the renewal of the corneal epithelium. Their deficiency is responsible for the conjunctivization of the cornea that is seen in different ocular pathologies, both in humans and in the canine species. The canine species represents an interesting preclinical animal model in ocular surface pathologies. However, the role of LSCs in physiological and pathological conditions in canine species is not well understood. Our objective was to characterize for the first time the soluble factors and the proteomic profile of the secretome and exosomes of canine LSCs (cLSCs). In addition, given the important role that fibroblasts play in the repair of the ocular surface, we evaluated the influence of the secretome and exosomes of cLSCs on their proliferation in vitro. Our results demonstrated a secretory profile of cLSCs with high concentrations of MCP-1, IL-8, VEGF-A, and IL-10, as well as significant production of exosomes. Regarding the proteomic profile, 646 total proteins in the secretome and 356 in exosomes were involved in different biological processes. Functionally, the cLSC secretome showed an inhibitory effect on the proliferation of fibroblasts in vitro, which the exosomes did not. These results open the door to new studies on the possible use of the cLSC secretome or some of its components to treat certain pathologies of the ocular surface in canine species.


2011 ◽  
Vol 7 (4) ◽  
pp. 935-947 ◽  
Author(s):  
Hasan Mahmud Reza ◽  
Boon-Yee Ng ◽  
Federico Luengo Gimeno ◽  
Toan Thang Phan ◽  
Leonard Pek-Kiang Ang

2008 ◽  
Vol 18 (6) ◽  
pp. 886-890 ◽  
Author(s):  
E. Wylegala ◽  
D. Dobrowolski ◽  
D. Tarnawska ◽  
D. Janiszewska ◽  
B. Gabryel ◽  
...  

2020 ◽  
Vol 15 (3) ◽  
pp. 211-218
Author(s):  
Mohamed Salih ◽  
Bakiah Shaharuddin ◽  
Samar Abdelrazeg

Organ and tissue transplantation are limited by the scarcity of donated organs or tissue sources. The success of transplantation is limited by the risk of disease transmission and immunological- related rejection. There is a need for new strategies and innovative solutions to make transplantation readily available, safer and with less complications to increase the success rates. Accelerating progress in stem cell biology and biomaterials development have pushed tissue and organ engineering to a higher level. Among stem cells repertoire, Mesenchymal Stem Cells (MSC) are gaining interest and recognized as a cell population of choice. There is accumulating evidence that MSC growth factors, its soluble and insoluble proteins are involved in several key signaling pathways to promote tissue development, cellular differentiation and regeneration. MSC as multipotent non-hematopoietic cells with paracrine factors is advantageous for regenerative therapies. In this review, we discussed and summarized the important features of MSC including its immunomodulatory properties, mechanism of homing in the direction of tissue injury, licensing of MSC and the role of MSC soluble factors in cell-free therapy. Special consideration is highlighted on the rapidly growing research interest on the roles of MSC in ocular surface regeneration.


2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Tiago Ramos ◽  
Deborah Scott ◽  
Sajjad Ahmad

The human ocular surface (front surface of the eye) is formed by two different types of epithelia: the corneal epithelium centrally and the conjunctival epithelium that surrounds this. These two epithelia are maintained by different stem cell populations (limbal stem cells for the corneal epithelium and the conjunctival epithelial stem cells). In this review, we provide an update on our understanding of these epithelia and their stem cells systems, including embryology, new markers, and controversy around the location of these stem cells. We also provide an update on the translation of this understanding into clinical applications for the treatment of debilitating ocular surface diseases.


Sign in / Sign up

Export Citation Format

Share Document